PhRMA’s False Claims About “Unintended Consequences” of the Inflation Reduction Act

Reports | February 11, 2025

Between September 2024 and mid-January 2025, PhRMA spent over $235,800 on 128 Meta ads to attack the Inflation Reduction Act’s drug price reforms.

Click here to download full report

P4AD-PharmaFalseClaimsReport-FINAL1